Showing results (21-30 of 62) with videos related to

Sort By:
Pageof 7
Frontiers in Psychology|May 1, 2025
Motor and cognitive function after unipolar depressive episodes: a 6 years longitudinal observational studyStephanie Straub, Markus A Hobert, Kirsten Emmert, et al.
Frontiers in Aging Neuroscience|October 30, 2024
Machine learning-based personalized composite score dissects risk and protective factors for cognitive and motor function in older participantsAnn-Kathrin Schalkamp, Stefanie Lerche, Isabel Wurster, et al.
NPJ Parkinson'S Disease|April 22, 2024
Longitudinal cognitive decline characterizes the profile of non-PD-manifest GBA1 mutation carriersBenjamin Roeben, Inga Liepelt-Scarfone, Stefanie Lerche, et al.
NPJ Parkinson'S Disease|June 13, 2025
Elevated cerebrospinal fluid levels of SERPIN E1 in participants with lewy body diseasesMilan Zimmermann, Madeleine Fandrich, Meike Jakobi, et al.
Journal of Parkinson'S Disease|September 6, 2024
Tissue Factor and Its Cerebrospinal Fluid Protein Profiles in Parkinson's DiseaseMilan Zimmermann, Madeleine Fandrich, Meike Jakobi, et al.
Parkinsonism & Related Disorders|June 13, 2026
Impact of genetic variants in the longevity gene PPARGC1A and cerebrospinal fluid PPARγ levels on clinical trajectories in Parkinson's disease: Potential biomarkers for neurodegeneration and ageingMadeleine Fandrich, Claudia Schulte, Meike Jakobi, et al.
Brain : a Journal of Neurology|April 26, 2022
The prodromal phase of hereditary spastic paraplegia type 4: the preSPG4 cohort studyTim W Rattay, Maximilian Völker, Maren Rautenberg, et al.
European Journal of Neurology|January 15, 2021
The longevity gene Klotho and its cerebrospinal fluid protein profiles as a modifier for Parkinson´s diseaseMilan Zimmermann, Leonie Köhler, Marketa Kovarova, et al.
NPJ Parkinson'S Disease|December 1, 2025
Quantification of cerebrospinal fluid α-synuclein seeds by endpoint dilution seed amplification assay in Parkinson's diseaseKathrin Brockmann, Alice Ticca, Stefanie Lerche, et al.
Frontiers in Neurology|March 14, 2022
CSF and Serum Levels of Inflammatory Markers in PD: Sparse Correlation, Sex Differences and Association With Neurodegenerative BiomarkersStefanie Lerche, Milan Zimmermann, Isabel Wurster, et al.
Pageof 7